Research Summary
Chemotherapy-induced nausea and vomiting (CINV) drugs are medications specifically designed to prevent or alleviate the symptoms of nausea and vomiting caused by chemotherapy treatments. Chemotherapy, a common cancer treatment, can trigger the release of certain chemicals in the body that stimulate the vomiting center in the brain, leading to CINV in many patients. CINV drugs work by targeting receptors in the brain and gastrointestinal tract, suppressing the signals that trigger nausea and vomiting. These drugs can be given before, during, or after chemotherapy sessions, and they are essential in improving the quality of life for cancer patients by reducing the distressing side effects associated with chemotherapy. CINV drugs are available in various forms, including oral tablets, injections, and patches, and their use is determined based on the individual patient's condition, the type of chemotherapy regimen, and the risk of developing CINV. Effective management of CINV is crucial to support cancer patients throughout their treatment and help them complete their therapy successfully.
According to DIResearch's in-depth investigation and research, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs include Heron Therapeutics, Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Roche, Mylan, Baxter, GSK, Helsinn, Southwest Pharma, Haisco, Sun Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Include:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Segment Include:
5-HT3 Inhibitors
NK1 Inhibitors
Others
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Application Include:
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry PESTEL Analysis
Chapter 3: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Regional Market Size and Forecast Analysis
Chapter 5: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview 1.1 Product Definition and Statistical Scope 1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product by Type 1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 5-HT3 Inhibitors 1.2.3 NK1 Inhibitors 1.2.4 Others 1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product by Application 1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Acute CINV 1.3.3 Delayed CINV 1.3.4 Breakthrough CINV 1.3.5 Others 1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue Analysis (2019-2030) 1.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Development Status and Trends 1.5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Development Status Analysis 1.5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Development Trends Analysis 2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Analysis by Regions 4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Overall Market: 2023 VS 2024 VS 2030 4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Market Share by Region (2019-2024) 4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2025-2030) 5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type and Application 5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 6 North America 6.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 6.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 6.5 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 7.4 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 7.5 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 8.4 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 9.4 APAC (excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 9.5 APAC (excl. China) Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 10.4 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 10.5 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type 11.4 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application 11.5 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue by Key Manufacturers (2020-2024) 12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Analysis and Market Dynamic 12.2.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Heron Therapeutics 13.1.1 Heron Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Merck 13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Eisai 13.3.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Mundipharma 13.4.1 Mundipharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Qilu Pharma 13.5.1 Qilu Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Teva 13.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Novartis 13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Roche 13.8.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Mylan 13.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Baxter 13.10.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 GSK 13.11.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Helsinn 13.12.1 Helsinn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Southwest Pharma 13.13.1 Southwest Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Haisco 13.14.1 Haisco Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Sun Pharma 13.15.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio 13.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis 14.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Downstream Customers 14.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support